390 related articles for article (PubMed ID: 18948405)
1. Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.
Singh R; Bhasin S; Braga M; Artaza JN; Pervin S; Taylor WE; Krishnan V; Sinha SK; Rajavashisth TB; Jasuja R
Endocrinology; 2009 Mar; 150(3):1259-68. PubMed ID: 18948405
[TBL] [Abstract][Full Text] [Related]
2. Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action.
Braga M; Bhasin S; Jasuja R; Pervin S; Singh R
Mol Cell Endocrinol; 2012 Mar; 350(1):39-52. PubMed ID: 22138414
[TBL] [Abstract][Full Text] [Related]
3. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
Singh R; Artaza JN; Taylor WE; Braga M; Yuan X; Gonzalez-Cadavid NF; Bhasin S
Endocrinology; 2006 Jan; 147(1):141-54. PubMed ID: 16210377
[TBL] [Abstract][Full Text] [Related]
4. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway.
Singh R; Artaza JN; Taylor WE; Gonzalez-Cadavid NF; Bhasin S
Endocrinology; 2003 Nov; 144(11):5081-8. PubMed ID: 12960001
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
[TBL] [Abstract][Full Text] [Related]
7. Androgen activates β-catenin signaling in bladder cancer cells.
Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
[TBL] [Abstract][Full Text] [Related]
8. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter.
Liu XH; Wu Y; Yao S; Levine AC; Kirschenbaum A; Collier L; Bauman WA; Cardozo CP
J Biol Chem; 2013 Jun; 288(25):17990-8. PubMed ID: 23649620
[TBL] [Abstract][Full Text] [Related]
9. Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin.
Gentile MA; Nantermet PV; Vogel RL; Phillips R; Holder D; Hodor P; Cheng C; Dai H; Freedman LP; Ray WJ
J Mol Endocrinol; 2010 Jan; 44(1):55-73. PubMed ID: 19726620
[TBL] [Abstract][Full Text] [Related]
10. The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways.
Guo W; Flanagan J; Jasuja R; Kirkland J; Jiang L; Bhasin S
J Biol Chem; 2008 Apr; 283(14):9136-45. PubMed ID: 18203713
[TBL] [Abstract][Full Text] [Related]
11. Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression.
Kanno Y; Ota R; Someya K; Kusakabe T; Kato K; Inouye Y
Biol Pharm Bull; 2013; 36(9):1460-5. PubMed ID: 23995658
[TBL] [Abstract][Full Text] [Related]
12. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network.
Lagathu C; Christodoulides C; Virtue S; Cawthorn WP; Franzin C; Kimber WA; Nora ED; Campbell M; Medina-Gomez G; Cheyette BN; Vidal-Puig AJ; Sethi JK
Diabetes; 2009 Mar; 58(3):609-19. PubMed ID: 19073771
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.
Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD
Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662
[TBL] [Abstract][Full Text] [Related]
15. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
Clifford RL; Deacon K; Knox AJ
J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone administration or G{alpha}q overexpression induces {beta}-catenin/T-Cell factor signaling and growth via increasing association of estrogen receptor-{beta}/Dishevelled2 in androgen-independent prostate cancer cells.
Liu X; Arnold JT; Blackman MR
Endocrinology; 2010 Apr; 151(4):1428-40. PubMed ID: 20176724
[TBL] [Abstract][Full Text] [Related]
17. Trenbolone enhances myogenic differentiation by enhancing β-catenin signaling in muscle-derived stem cells of cattle.
Zhao JX; Hu J; Zhu MJ; Du M
Domest Anim Endocrinol; 2011 May; 40(4):222-9. PubMed ID: 21402455
[TBL] [Abstract][Full Text] [Related]
18. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
19. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
20. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
